Thermo Fisher stock price today: TMO steadies near a 52-week high ahead of Jan. 29 earnings
Thermo Fisher Scientific Inc shares rose $2.03, or 0.3%, to $638.33 on Thursday afternoon, after briefly climbing as high as $643.66 earlier in the session.
Thermo Fisher stock price holds near a fresh 52-week high with earnings next week in focus
Shares of Thermo Fisher Scientific Inc hit a fresh 52-week high Thursday, closing up 0.5% at $639.43. After hours trading saw little movement, with the stock at $639.45 following the 4 p.m. ET bell. During the session, prices fluctuated between $633.51 and $643.66.
Thermo Fisher stock hits fresh 52-week high as volume jumps in late trade
Thermo Fisher Scientific Inc shares climbed 2.8%, closing at $636.30 on Wednesday and hitting a new 52-week high. After hours, the stock barely moved following heavy volume earlier in the day. The S&P 500 advanced 1.16%, while the Dow added 1.21%.
Thermo Fisher (TMO) stock rises as Goldman lifts target ahead of Jan. 29 earnings
Thermo Fisher Scientific shares climbed roughly 1.6% to $628.63 by midday Wednesday, beating the wider market gains.
Thermo Fisher stock price rises nearly 2% as Australia starts Clario deal review; earnings next in focus
Thermo Fisher Scientific Inc shares climbed roughly 1.9% to $630.48 Wednesday, outpacing the broader market as investors digested new regulatory developments around its planned Clario acquisition. The stock hit an intraday high of $631.25 earlier in the session.
Thermo Fisher stock price holds near $619 after-hours as tariff fears slam Wall Street
Shares of Thermo Fisher Scientific Inc closed Tuesday up 26 cents at $619.01 and showed little movement after hours, following the 4 p.m. close. The stock traded between $607.37 and $620.75 during the session, with roughly 3.1 million shares changing hands.
Thermo Fisher stock slips as Australia opens Clario deal review — what investors watch next
Shares of Thermo Fisher Scientific Inc slipped on Tuesday following Australia’s competition watchdog launching a Phase 1 initial assessment of its planned acquisition of clinical-trial tech company Clario Holdings. The case, listed as MN-01075 in the regulator’s acquisitions register, had a market questionnaire issued on Jan. 19, with the determination period set to end on March 2. TMO shares fell 0.2% to $617.27 in early afternoon trading.
Thermo Fisher Scientific stock drops before long weekend as TMO traders brace for Jan. 29 earnings
Thermo Fisher Scientific Inc closed Friday down 0.95% at $618.72, following a weak session for many life-sciences stocks as the broader market slipped.
Thermo Fisher stock pulls back from near-$630: what to know before earnings
Shares of Thermo Fisher Scientific Inc slipped Friday, surrendering early gains after hitting just below $630. The stock finished at $618.72, down 0.95%, with trading ranging from $618.71 to $629.73, per Investing.com data.
Thermo Fisher Scientific stock slips into long weekend as TMO traders eye Jan. 29 earnings
Thermo Fisher Scientific shares dipped 0.9% to close at $618.72 on Friday, then stayed close to that price in after-hours trading. During the day, the stock fluctuated between $618.20 and $629.50. Trading volume hit roughly 2.9 million shares, matching its typical daily activity.
Thermo Fisher (TMO) stock rises again as CEO points to U.S. reshoring contracts
Thermo Fisher Scientific shares rose roughly 0.7% to hit $626.17 by midday Thursday, building on gains from the day before.
Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom
Shares of Thermo Fisher Scientific climbed 2.4% to close at $621.83 on Wednesday, then held steady after hours. The stock fluctuated between $604.50 and $623.99 during the session, with roughly 2.46 million shares changing hands.
Thermo Fisher Scientific stock rises on reshoring contract talk, Nvidia lab deal and exec shuffle
Shares of Thermo Fisher Scientific climbed 1.4% to $615.46 Wednesday after CEO Marc Casper announced that the company’s pharma services division secured contracts linked to “reshoring” — shifting drug manufacturing back from Europe and Asia to the U.S. Speaking at the J.P. Morgan Healthcare Conference, Casper highlighted “a very big focus on reshoring” and noted that a delayed proposed 100% tariff on imported medicines has already prompted customers to accelerate projects and reconsider pricing. Evercore ISI analyst Vijay Kumar described the outlook as “constructive.” Casper also referenced Thermo’s acquisition of Sanofi’s Ridgefield, New Jersey facility last year as a capacity boost and mentioned improving biotech funding.
Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus
Thermo Fisher Scientific’s pharmaceutical services unit has secured contracts to assist clients shifting drug manufacturing from Europe or Asia back to the U.S., CEO Marc Casper revealed Tuesday. Shares slipped 1.4% to close at $607.08. Casper highlighted a strong push toward reshoring production and operations to the U.S., calling it a boost for 2027 and 2028 as a proposed 100% tariff on imported medicines looms.
Thermo Fisher stock slides as Nvidia AI lab deal meets COO exit and March reshuffle
Shares of Thermo Fisher Scientific dropped roughly 2% Tuesday, deepening a retreat in the life-sciences tools sector. The decline came despite the firm announcing a fresh strategic partnership with Nvidia and revealing some executive departures.
Thermo Fisher (TMO) stock slips after-hours after Nvidia lab-automation tie-up, exec shake-up
Thermo Fisher Scientific Inc shares slipped roughly 0.5% in Monday’s after-hours session, following the life-sciences tools company’s announcement of a fresh partnership with Nvidia and a shake-up in its leadership team.
Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk
Shares of Thermo Fisher Scientific dropped Monday following a regulatory filing revealing that its chief operating officer plans to exit later this quarter amid a reshuffle of the company’s senior leadership. The stock slipped 1.8% to $607.56, cooling off from an earlier high of $624.14.
Nvidia stock wobbles after $1B Eli Lilly AI lab plan as CPI and TSMC loom
Nvidia, the world’s most valuable listed company, and Eli Lilly said on Monday they will spend $1 billion over five years on a joint research lab in the San Francisco Bay Area, betting Nvidia’s next Vera Rubin AI chips can speed drug discovery. Nvidia shares were down 0.2% at $184.42 by 10:30 a.m. ET.
Thermo Fisher stock rises as Stifel lifts target; JPM conference and Jan. 29 earnings in focus
Thermo Fisher Scientific shares closed up on Friday, heading into the week with two key dates marked: a management update at the J.P. Morgan Healthcare Conference and the company's quarterly earnings release later this month.
Thermo Fisher Scientific Inc stock: Weaverville phase-out plan hits tape ahead of JPM talk, Jan. 29 earnings
Thermo Fisher Scientific is set to wind down its Weaverville-area facility in western North Carolina, according to a WARN notice filed with the state. The document reveals permanent layoffs starting as early as Dec. 31, 2026, with the eventual closure slated for late 2027. The company plans to cut 421 jobs at its 275 Aiken Road site, beginning the first wave of separations at the end of 2026 and continuing through the following year.
TechStock² Updates
